New combo therapy aims to shrink pancreatic tumors before surgery
NCT ID NCT04894643
First seen Apr 24, 2026 · Last updated May 15, 2026 · Updated 8 times
Summary
This study tests a treatment plan for people with borderline resectable pancreatic cancer. Participants first receive chemotherapy, then proton radiation combined with more chemo, followed by surgery if possible. The goal is to see if this approach is safe and helps control the disease. About 10 adults will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of Surgery, LK Wiener Neustadt
RECRUITINGWiener Neustadt, 2700, Austria
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
EBG MedAustron GmbH
RECRUITINGWiener Neustadt, Lower Austria, 2700, Austria
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.